Stratasys PolyJet technology and Materialise FDA-cleared software now most versatile 3D printing system for hospitals and physicians to build anatomical models at the point-of-care

Stratasys PolyJet technology and Materialise FDA-cleared software now most versatile 3D printing system for hospitals and physicians to build anatomical models at the point-of-care.

MINNEAPOLIS & REHOVOT, Israel--(BUSINESS WIRE)

Further bringing 3D printed medical models to life, Stratasys is expanding the suite of printers and materials validated by its collaborator Materialise as part of FDA-cleared Materialise Mimics inPrint software. The end result is the most versatile 3D printing system for point-of-care across hospitals and physicians - advancing production of patient-specific, life-like anatomical models for diagnostic purposes in conjunction with other tools and expert clinical judgement.

PolyJet multi-material and multi-color solutions validated now include the J750 and J735 3D Printers and the high-performance desktop Objet30 Prime 3D Printer. Materialise Mimics inPrint is the first and currently only 3D printing software cleared by the FDA to create anatomical models for patient care. The software is designed to allow physicians and hospitals to leverage 3D printing at point-of-care - building a trusted and reliable source for surgical planning and interdisciplinary communication.

“Historically, pre-surgical planning relied on 2D imaging requiring physicians to mentally reconstruct the patient anatomy. But 3D printing evolves this approach by putting precise replicas of patient anatomy directly in physician hands. Our collaboration with Materialise is a huge step towards unlocking the potential of this technology for patient care,” says Eyal Miller, Head of Healthcare Business Unit, Stratasys. “Now the 3D printer that every hospital needs to power their medical modeling comes with additional options for an FDA-cleared software solution.”

In March of 2018, Materialise Mimics inPrint was cleared by the FDA, becoming the only solution with 510(k) clearance as an end-to-end 3D printing solution, as well as a fully comprehensive 3D printing solution for anatomical modeling. According to company reports, of the top 20 U.S. hospitals as ranked by U.S. News & World Report, 16 have implemented a medical 3D printing strategy using Materialise Mimics technology.

Photo: Model of patient's left atrial appendage (LAA) created with Stratasys and Materialise technology is intended to allow surgeons to select the appropriate device and plan the optimal approach to occlude the LAA. Image provided by Materialise.

“By validating Stratasys’ 3D printing technologies through our certification process, we’re giving doctors and hospitals improved access to high-quality anatomical models for personalized care to patients,” said Bryan Crutchfield, Vice President and General Manager of Materialise North America. “The addition of multi-color and multi-material printers to the list of validated printers is aimed to enable healthcare providers to implement a versatile offering that can support their most complex cases across a wide range of surgical specialties on a single printer. At Materialise, we take a hardware-agnostic approach to software development, offering the flexibility to partner with other leaders in the 3D printing industry like Stratasys – a company committed to addressing requirements of the medical community.”

The Stratasys J735/J750 3D Printers are able to develop highly-complex models using multiple textures, while combining hard and soft materials to mimic human tissue. The unique combination of transparency with multiple color re-creation ensures practitioners can differentiate anatomy, view critical structures within an organ replica, and create realistic representations of any bone, tissue, and organ.

The Stratasys’ Objet30 Prime 3D Printer is a cost-effective, desktop platform providing an entry point to hospitals seeking a point-of-care printing solution - without compromising quality, resolution or accuracy. The versatile offering supports a range of anatomical models and applications, including orthopedic, cardiac, neurosurgery and other use-cases for visualization, surgical planning, training and education.

Source: Stratasys

Comments

No comments to display.

Related posts

Hadron Therapy Industry 2019-2025: Global Size, Share, Emerging Trends, Demand, Revenue and Forecasts Research

Hadron Therapy Industry 2019 Global Market research report studies latest Hadron Therapy industry aspects market size, share, trends, growth, business overview and Hadron Therapy industry scenario during the forecast period (2019-2025).

Acid Catalysts Industry 2019: Global Market Size, Growth, Share, Insights, Supply, Drivers, Demand, Outlook, Trends and Forecasts 2025

A latest report has been added to the wide database of Orian Research Consultant titled “Global Acid Catalysts Market Research Report (2025)” which provides an outlook of current market value, Size, Share, Growth, Trends and Forecast.
3 days ago

Continuous Renal Replacement Therapy Industry 2019 Global Market Size, Share, Growth, Sales and Drivers Analysis Research Report 2025

Continuous Renal Replacement Therapy Industry 2019 Global Market Research report provides information regarding market size, share, trends, growth, cost structure, capacity, and revenue and forecast 2025.

Black Pellets Industry 2019 Global Market Size, Outlook, Demand, Key Manufacturers and 2025 Forecast

A recent market report published on the “Black Pellets Industry” presents an in-depth overview of the Black Pellets industry. Global Black Pellets market research report covers the overview, summary, Black Pellets market dynamics, competitive analysis, and leading player’s various strategies to sustain in the global market. Apart from this, the Black Pellets report also covers detail information about various clients which is the most significant element for the manufacturers.
3 days ago

Call for Applications: Startup World Cup 2019

Startup World Cup ("SWC") offers innovation and entrepreneurship opportunities for startup ecosystems around the world. This platform consists of a global series of startup conferences and competitions that bring together phenomenal startups, VCs, and world-class tech CEOs.
Application Deadline in 2 months

EU Call for Proposals: Information and promotion about the sustainable aspect of rice production

The objective is to highlight the sustainable aspect of rice sector. Rice production in Europe has a particular environmental dimension, being at the heart of the preservation of certain wetlands. Rice cultivation is a sensitive and specific practice at European level, since it is produced in areas where there are few crop alternatives. Its preservation and improvement contribute to the sustainability of rice producing regions, by playing an active role in maintaining rural areas, protecting nature and preserving biodiversity. Actions shall highlight the environmental sustainability of the production, stressing its beneficial role for climate action and the environment.
Application Deadline in 22 days

A low-cost and open-source platform for automated imaging

Remote monitoring of plants using hyperspectral imaging has become an important tool for the study of plant growth, development, and physiology. Many applications are oriented towards use in field environments to enable non-destructive analysis of crop responses due to factors such as drought, nutrient deficiency, and disease, e.g., using tram, drone, or airplane mounted instruments.

Can developing nations compete in a digital world?

People want in on e-commerce for simple reasons - choice, ease, speed, cost, convenience. Yet not everyone benefits equally, especially in least developed countries.